PCSK6
Proprotein convertase subtilisin/kexin type 6
Also known as: PACE4, PCSK6_HUMAN, SPC4
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P29122
- Gene
- PCSK6
- Ensembl
- ENSG00000140479
- Chromosome
- 15
- Canonical length
- 969 aa
- Protein class
- Enzymes, Predicted intracellular proteins, Predicted secreted proteins
- Secretome location
- Secreted to extracellular matrix
OverviewNCBI Gene
This gene encodes a member of the subtilisin-like proprotein convertase family, which includes proteases that process protein and peptide precursors trafficking through regulated or constitutive branches of the secretory pathway. The encoded protein undergoes an initial autocatalytic processing event in the ER to generate a heterodimer which exits the ER and sorts to the trans-Golgi network where a second autocatalytic event takes place and the catalytic activity is acquired. The encoded protease is constitutively secreted into the extracellular matrix and expressed in many tissues, including neuroendocrine, liver, gut, and brain. This gene encodes one of the seven basic amino acid-specific members which cleave their substrates at single or paired basic residues. Some of its substrates include transforming growth factor beta related proteins, proalbumin, and von Willebrand factor. This gene is thought to play a role in tumor progression and left-right patterning. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Feb 2014]
Canonical amino-acid sequenceUniProt
969 residues, UniProt reviewed canonical sequence.
>P29122|PCSK6
1 MPPRAPPAPG PRPPPRAAAA TDTAAGAGGA GGAGGAGGPG FRPLAPRPWR WLLLLALPAA
61 CSAPPPRPVY TNHWAVQVLG GPAEADRVAA AHGYLNLGQI GNLEDYYHFY HSKTFKRSTL
121 SSRGPHTFLR MDPQVKWLQQ QEVKRRVKRQ VRSDPQALYF NDPIWSNMWY LHCGDKNSRC
181 RSEMNVQAAW KRGYTGKNVV VTILDDGIER NHPDLAPNYD SYASYDVNGN DYDPSPRYDA
241 SNENKHGTRC AGEVAASANN SYCIVGIAYN AKIGGIRMLD GDVTDVVEAK SLGIRPNYID
301 IYSASWGPDD DGKTVDGPGR LAKQAFEYGI KKGRQGLGSI FVWASGNGGR EGDYCSCDGY
361 TNSIYTISVS SATENGYKPW YLEECASTLA TTYSSGAFYE RKIVTTDLRQ RCTDGHTGTS
421 VSAPMVAGII ALALEANSQL TWRDVQHLLV KTSRPAHLKA SDWKVNGAGH KVSHFYGFGL
481 VDAEALVVEA KKWTAVPSQH MCVAASDKRP RSIPLVQVLR TTALTSACAE HSDQRVVYLE
541 HVVVRTSISH PRRGDLQIYL VSPSGTKSQL LAKRLLDLSN EGFTNWEFMT VHCWGEKAEG
601 QWTLEIQDLP SQVRNPEKQG KLKEWSLILY GTAEHPYHTF SAHQSRSRML ELSAPELEPP
661 KAALSPSQVE VPEDEEDYTA QSTPGSANIL QTSVCHPECG DKGCDGPNAD QCLNCVHFSL
721 GSVKTSRKCV SVCPLGYFGD TAARRCRRCH KGCETCSSRA ATQCLSCRRG FYHHQEMNTC
781 VTLCPAGFYA DESQKNCLKC HPSCKKCVDE PEKCTVCKEG FSLARGSCIP DCEPGTYFDS
841 ELIRCGECHH TCGTCVGPGR EECIHCAKNF HFHDWKCVPA CGEGFYPEEM PGLPHKVCRR
901 CDENCLSCAG SSRNCSRCKT GFTQLGTSCI TNHTCSNADE TFCEMVKSNR LCERKLFIQF
961 CCRTCLLAGLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PCSK6 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 149 nTPM
Expression across tissuesHPA
Tissue
- liver: 149 nTPM
- spinal cord: 109 nTPM
- spleen: 77 nTPM
- midbrain: 34 nTPM
- placenta: 30 nTPM
- cerebral cortex: 20 nTPM
Single-cell type
- retinal horizontal cells: 1,745 nCPM
- bergmann glia: 979 nCPM
- oligodendrocytes: 636 nCPM
- hepatocytes: 631 nCPM
- pituitary stem cells: 376 nCPM
- platelets: 342 nCPM
Immune cell
- NK-cell: 3.3 nTPM
- non-classical monocyte: 1.3 nTPM
- total PBMC: 1.2 nTPM
- naive B-cell: 1 nTPM
- eosinophil: 0.9 nTPM
- basophil: 0.7 nTPM
Brain region
- white matter: 323 nTPM
- medulla oblongata: 259 nTPM
- pons: 179 nTPM
- basal ganglia: 150 nTPM
- midbrain: 147 nTPM
- cerebellum: 133 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.73
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.41
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- determination of left/right symmetry
- glycoprotein metabolic process
- nerve growth factor production
- peptide hormone processing
- plasma lipoprotein particle remodeling
- protein processing
- regulation of BMP signaling pathway
- secretion by cell
- zygotic determination of anterior/posterior axis, embryo
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Peptidase S8/S53 domain
- EGF-like domain
- P domain
- Furin-like repeat
- Galactose-binding-like domain superfamily
- Growth factor receptor cysteine-rich domain superfamily
- PLAC
- Peptidase S8, subtilisin-related
- Peptidase S8, subtilisin, His-active site
- Peptidase S8, subtilisin, Asp-active site
- Peptidase S8, subtilisin, Ser-active site
- Growth factor receptor domain 4
- Peptidase S8, pro-domain
- Kexin/furin catalytic domain
- Peptidase S8/S53 domain superfamily
- Peptidase S8, pro-domain superfamily
- Subtilase family
- Proprotein convertase P-domain
- PLAC (protease and lacunin) domain
- Growth factor receptor domain IV
- Peptidase S8 pro-domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PCSK6 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PCSK6 as an antibody target. Whether an autoantibody or antibody against PCSK6 could matter depends on whether native PCSK6 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PCSK6 is annotated as secreted, so native PCSK6 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label PCSK6 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...